Does estrogen cause secondary amenorrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Estrogen Cause Secondary Amenorrhea?

No, low estrogen levels are typically associated with secondary amenorrhea rather than estrogen causing it. In fact, estrogen deficiency is a common finding in women with secondary amenorrhea, particularly in those with functional hypothalamic amenorrhea.

Relationship Between Estrogen and Amenorrhea

  • Secondary amenorrhea is often characterized by systemic reductions in estradiol levels, not excess estrogen 1
  • Low energy availability (EA) disrupts the hypothalamic-pituitary-gonadal (HPG) axis, leading to disruptions in luteinizing hormone (LH) pulsatility, which in turn causes menstrual dysfunction manifesting as oligo-amenorrhea 1
  • These hormonal disruptions result in decreased estradiol and progesterone levels, not increased levels 1

Common Causes of Secondary Amenorrhea

  • Functional Hypothalamic Amenorrhea (FHA) accounts for 20-35% of secondary amenorrhea cases and is characterized by low estrogen levels 2
  • Polycystic Ovary Syndrome (PCOS) is another common cause of secondary amenorrhea but is typically associated with hormonal imbalances including elevated androgens rather than estrogen excess 2
  • Hyperprolactinemia accounts for approximately 20% of secondary amenorrhea cases 2
  • Primary Ovarian Insufficiency (POI) is characterized by elevated FSH and LH levels with low estrogen 2

Female Athlete Triad and RED-S

  • In female athletes, the well-established female athlete triad involves perturbations of energy availability, bone health, and menstrual status 1
  • Low energy availability causes disruptions of LH pulsatility, which disturbs gonadotropin release, resulting in menstrual dysfunction 1
  • These hormonal changes include decreased estradiol, decreased progesterone, decreased leptin, increased ghrelin, and other hormonal alterations 1
  • When estrogen levels are aberrantly subphysiologic (not elevated), osteoclast activity predominates and bone mass is lost 1

Treatment Approaches

  • For women with secondary amenorrhea who have normal estrogen levels but are not menstruating, progesterone therapy may be used to induce withdrawal bleeding 3
  • For women with secondary amenorrhea due to low estrogen levels, estrogen replacement therapy may be necessary 1
  • Amenorrhea in contraceptive implant users is generally not harmful and does not require medical treatment 1
  • Treatment of hypogonadism aims to normalize ovarian hormone levels through estrogen replacement with oral, micronized, or transdermal preparations 1

Diagnostic Considerations

  • Initial laboratory evaluation for secondary amenorrhea should include serum FSH, LH, prolactin, and TSH levels 2
  • Different patterns of LH, FSH, and estradiol can help classify the type of secondary amenorrhea 4
  • Patients with hypothalamic-pituitary failure typically have low or low-normal levels of LH, FSH, and low estradiol 4

Clinical Implications

  • Secondary amenorrhea with low estrogen levels increases risk for decreased bone mineral density and stress fractures 1
  • In the setting of oligo-amenorrhea with low estrogen, bone microarchitecture is negatively affected, leading to decreased trabecular number and cortical thickness 1
  • These changes result in decreased stiffness and lower failure load, ultimately increasing the incidence of bone stress injury 1

In summary, estrogen deficiency rather than excess is typically associated with secondary amenorrhea, particularly in cases related to functional hypothalamic amenorrhea, female athlete triad, and primary ovarian insufficiency.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Causes of Amenorrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cyclical dydrogesterone in secondary amenorrhea: results of a double-blind, placebo-controlled, randomized study.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2007

Research

Classification of secondary amenorrhea based on distinct hormonal patterns.

The Journal of clinical endocrinology and metabolism, 1975

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.